These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 33930657)
1. Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer. Guyot D'Asnières De Salins A; Tachon G; Cohen R; Karayan-Tapon L; Junca A; Frouin E; Godet J; Evrard C; Randrian V; Duval A; Svrcek M; Lascols O; Vignot S; Coulet F; André T; Fléjou JF; Cervera P; Tougeron D ESMO Open; 2021 Jun; 6(3):100120. PubMed ID: 33930657 [TBL] [Abstract][Full Text] [Related]
2. Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type. Matsubayashi H; Oishi T; Sasaki K; Abe M; Kiyozumi Y; Higashigawa S; Niiya F; Sato J; Ishiwatari H; Imai K; Hotta K; Kishida Y; Takada K; Ono H; Yamazaki K; Yasui H; Kenmotsu H; Kado N; Kagawa H; Shiomi A; Sugiura T; Bando E; Nishimura S; Hatakeyama K; Serizawa M; Harada R; Sugino T Hum Pathol; 2023 May; 135():54-64. PubMed ID: 36596344 [TBL] [Abstract][Full Text] [Related]
3. Testing for Microsatellite Instability in Colorectal Cancer - a Comparative Evaluation of Immunohistochemical and Molecular Methods. Vg DR; Nayanar SK; Gopinath V; Philip KJ; Aryadan N; Nair V; Perumal V Gulf J Oncolog; 2022 May; 1(39):70-78. PubMed ID: 35695349 [TBL] [Abstract][Full Text] [Related]
4. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases]. Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997 [No Abstract] [Full Text] [Related]
5. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair]. Zhang YH; Wu HW; Wang J; Liang ZY Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653 [No Abstract] [Full Text] [Related]
6. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of mismatch-repair and microsatellite-instability status in a Chinese colorectal cancer Cohort. Zhang P; Wang A; Bian C; Zhang J; Jiang C; Zhou H Asian J Surg; 2024 Feb; 47(2):959-967. PubMed ID: 38185557 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers. Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245 [TBL] [Abstract][Full Text] [Related]
9. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078 [TBL] [Abstract][Full Text] [Related]
10. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers. Park Y; Nam SK; Seo SH; Park KU; Oh HJ; Park YS; Suh YS; Ahn SH; Park DJ; Kim HH; Lee HS J Gastric Cancer; 2023 Apr; 23(2):264-274. PubMed ID: 37129151 [TBL] [Abstract][Full Text] [Related]
12. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer. Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D PeerJ; 2023; 11():e15920. PubMed ID: 37663290 [TBL] [Abstract][Full Text] [Related]
13. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods. Yang RK; Chen H; Roy-Chowdhuri S; Rashid A; Alvarez H; Routbort M; Patel KP; Luthra R; Medeiros LJ; Toruner GA Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230473 [TBL] [Abstract][Full Text] [Related]
15. High homogeneity of mismatch repair deficiency in advanced prostate cancer. Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435 [TBL] [Abstract][Full Text] [Related]
16. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing. Kim H; Kim HS Anticancer Res; 2023 Apr; 43(4):1785-1795. PubMed ID: 36974792 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature. Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176 [TBL] [Abstract][Full Text] [Related]
18. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status. Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ Pathology; 2010; 42(5):409-13. PubMed ID: 20632815 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer. Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]